Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 3;14(4):359.
doi: 10.3390/brainsci14040359.

The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review

Affiliations
Review

The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review

Petru Fabian Lungu et al. Brain Sci. .

Abstract

The majority of schizophrenia-affected individuals display deficiencies in multiple cognitive domains such as attention, working memory, long-term memory, and learning, deficiencies that are stable throughout the disease. The purpose of this narrative review was to examine the effect of antipsychotics on several cognitive domains affected by schizophrenia. Methods: We searched MEDLINE, Elsevier, Scopus, and DOAJ databases for randomized controlled trials and other studies investigating the effects of typical and atypical antipsychotics on cognition in patients with schizophrenia in studies conducted in the last decade. Results: The majority of studies included in this review showed that antipsychotics (especially SGAs) have positive effects on both cognition and general psychopathology of schizophrenia. We mention that treatment with antipsychotic substances represents an ongoing effort of the researchers, who are constantly searching for the best approach to meet the mental health needs of schizophrenia patients. Conclusions: Even with those positive results, it should be noted that more studies are needed in order to fully observe the various effects of certain antipsychotic substances on cognition.

Keywords: antipsychotics; cognition; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Risk of bias for the included studies.

Similar articles

Cited by

References

    1. WHO . International Statistical Classification of Diseases and Related Health Problems ICD-10: Instruction Manual. Volume 2. World Health Organization—WHO; Geneva, Switzerland: 2016. [(accessed on 5 November 2023)]. p. 252. Available online: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2016.pdf.
    1. Barrera A., Curwell-Parry O., Raphael M.-C. Hebephrenia is dead, long live hebephrenia, or why Hecker and Chaslin were on to something. BJPsych Adv. 2019;25:373–376. doi: 10.1192/bja.2019.24. - DOI
    1. Torrey E.F. The Epidemiology of Paranoid Schizophrenia. Schizophr. Bull. 1981;7:588–593. doi: 10.1093/schbul/7.4.588. - DOI - PubMed
    1. Stompe T., Ortwein-Swoboda G., Ritter K., Marquart B., Schanda H. The impact of diagnostic criteria on the prevalence of schizophrenic subtypes. Compr. Psychiatry. 2005;46:433–439. doi: 10.1016/j.comppsych.2005.03.003. - DOI - PubMed
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; Arlington, VA, USA: 2013. - DOI

LinkOut - more resources